Paxillin Antikörper (AA 217-266)
Kurzübersicht für Paxillin Antikörper (AA 217-266) (ABIN2885137)
Target
Alle Paxillin (PXN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 217-266
-
Spezifität
- Paxillin Antibodyantibody detects endogenous levels of Paxillin.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human Paxillin (aa217-266).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C.
-
-
- Paxillin (PXN)
-
Andere Bezeichnung
- PXN / Paxillin
-
Hintergrund
-
Name/Gene ID: PXN
Synonyms: PXN, Paxillin -
Gen-ID
- 5829
-
UniProt
- P49023
-
Pathways
- MAPK Signalweg, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Target
-